FDA Investigator

Comyar Shoghi

Latest inspection on record: Los Angeles, United States, October 2017 · records back to 2008

Human DrugsFoods & CosmeticsBiologicsMedical Devices & Rad Health

FDA inspection record · Last updated July 12, 2026

Overview

  • 158 inspections across 150 sites are on record.
  • 276 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2017-10-06.

At a glance

Inspections

158

Sites

150

Observations

276

Career since

Dec 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Said R. Beydoun, M.D.6 Oct 2017Biologics
Clinical Science Institute25 Sep 2017Human Drugs
Anthony Mills, MD1 Sep 2017Human Drugs
Peter J. Ruane, M.D.28 Feb 2017Human Drugs
SOUSEIKAI Sumida Hospital27 Jan 2017Human Drugs

Sites inspected

Said R. Beydoun, M.D.Los Angeles, United States1 insp.
Clinical Science InstituteSanta Monica, United States1 insp.
Anthony Mills, MDWest Hollywood, United States1 insp.
Peter J. Ruane, M.D.Los Angeles, United States1 insp.
SOUSEIKAI Sumida HospitalSumida, Japan1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Comyar Shoghi's 276 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site